SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0000950170-22-002545
Filing Date
2022-03-01
Accepted
2022-03-01 16:18:55
Documents
98
Period of Report
2021-12-31

Document Format Files

Seq Description Document Type Size
1 10-K reph-20211231.htm   iXBRL 10-K 3064901
2 EX-4.3 reph-ex4_3.htm EX-4.3 24331
3 EX-21.1 reph-ex21_1.htm EX-21.1 10820
4 EX-23.1 reph-ex23_1.htm EX-23.1 2667
5 EX-31.1 reph-ex31_1.htm EX-31.1 14886
6 EX-31.2 reph-ex31_2.htm EX-31.2 14864
7 EX-32.1 reph-ex32_1.htm EX-32.1 9562
  Complete submission text file 0000950170-22-002545.txt   12164220

Data Files

Seq Description Document Type Size
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT reph-20211231_pre.xml EX-101.PRE 520798
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT reph-20211231_lab.xml EX-101.LAB 700252
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT reph-20211231_def.xml EX-101.DEF 287178
11 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT reph-20211231_cal.xml EX-101.CAL 92063
12 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT reph-20211231.xsd EX-101.SCH 73295
92 EXTRACTED XBRL INSTANCE DOCUMENT reph-20211231_htm.xml XML 2248534
Mailing Address 1 E. UWCHLAN AVE, SUITE 112 EXTON PA 19341
Business Address 1 E. UWCHLAN AVE, SUITE 112 EXTON PA 19341 770-534-8239
Recro Pharma, Inc. (Filer) CIK: 0001588972 (see all company filings)

IRS No.: 261523233 | State of Incorp.: PA | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-36329 | Film No.: 22698305
SIC: 2834 Pharmaceutical Preparations